PAUL DORSETT: Open Payments
NPI 1265039341 · SWAINSBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 25 payments from 7 companies in 2025. Trend: 2023 $32 · 2024 $88 · 2025 $413
Food & beverage: $399Entertainment: $14
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $281 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Lilly USA, LLC | 1 | $23 |
| Organogenesis Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Optos, Inc. | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, ZEPBOUND, PURAPLY WOUND MATRIX, The Cologuard Plus Collection Kit, Qelbree, NFC-700.
Industry payments across GA — which companies pay providers there.
